Search Results - Federico Cappuzzo

Refine Results
  1. 1
    Crizotinib: from discovery to accelerated development to front-line treatment

    Crizotinib: from discovery to accelerated development to front-line treatment by Fiona Blackhall, Federico Cappuzzo

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    <i>HER2</i>Mutation and Response to Trastuzumab Therapy in Non–Small-Cell Lung Cancer

    <i>HER2</i>Mutation and Response to Trastuzumab Therapy in Non–Small-Cell Lung Cancer by Federico Cappuzzo, Lynne Bemis, Marileila Varella‐Garcia

    Published 2006
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  3. 3
    Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer

    Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer by Fred R. Hirsch, Marileila Varella‐Garcia, Federico Cappuzzo

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Targeting MET in Lung Cancer: Will Expectations Finally Be MET?

    Targeting MET in Lung Cancer: Will Expectations Finally Be MET? by Alexander Drilon, Federico Cappuzzo, Sai‐Hong Ignatius Ou, D. Ross Camidge

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

    Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial by Giovanni Luca Ceresoli, Federico Cappuzzo, Vanesa Gregorc, Stefania Bartolini, Lucio Crinò, Emmanuel Villa

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study

    Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: Re-analysis of the SATURN study by Julien Mazières, Wolfram Brugger, Federico Cappuzzo, Peter Middel, Alice Frosch, Ilze Bāra, Gaëlle Klingelschmitt, Barbara Klughammer

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens

    Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens by Francesco Grossi, Kaoru Kubota, Federico Cappuzzo, Filippo de Marinis, Cesare Gridelli, Marianna Aita, Jean‐Yves Douillard

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology

    Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology by Cesare Gridelli, Andrea Ardizzoni, Massimo Barberis, Federico Cappuzzo, Francesca Casaluce, Romano Danesi, Giancarlo Troncone, Filippo de Marinis

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy

    Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy by Bruno Coudert, Tudor‐Eliade Ciuleanu, K. Park, Yi‐Long Wu, Giuseppe Giaccone, Wolfram Brugger, P. Gopalakrishna, Federico Cappuzzo

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub

    KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub by Stefano Scalera, Marco Mazzotta, Clelia Cortile, Eriseld Krasniqi, Ruggero De Maria, Federico Cappuzzo, Gennaro Ciliberto, Marcello Maugeri‐Saccà

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis

    Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis by Barbara Melosky, Kato Kambartel, Maik Häntschel, M Bennetts, Dana J. Nickens, Julia Brinkmann, Antonin Kayser, Michael Moran, Federico Cappuzzo

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    cMET Exon 14 Skipping: From the Structure to the Clinic

    cMET Exon 14 Skipping: From the Structure to the Clinic by Nele Van Der Steen, Elisa Giovannetti, Patrick Pauwels, Godefridus J. Peters, David S. Hong, Federico Cappuzzo, Fred R. Hirsch, Christian Rolfo

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Gemcitabine and vinorelbine in pemetrexed‐pretreated patients with malignant pleural mesothelioma

    Gemcitabine and vinorelbine in pemetrexed‐pretreated patients with malignant pleural mesothelioma by Paolo Andrea Zucali, Giovanni Luca Ceresoli, I. Garassino, Fabio De Vincenzo, Raffaele Cavina, Elisabetta Campagnoli, Federico Cappuzzo, Silvia Salamina, Héctor Soto Parrà, Armando Santoro

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features

    Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features by Alessandra Capodanno, Laura Boldrini, Agnese Proietti, Greta Alì, S Pelliccioni, Cristina Niccoli, Armida D’Incecco, Federico Cappuzzo, Antonio Chella, Marco Lucchi, Alfredo Mussi, Gabriella Fontanini

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

    EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer by Marileila Varella‐Garcia, Joachim Diebold, David A. Eberhard, K Geenen, Astrid Hirschmann, Mark Kockx, Iris Nagelmeier, Josef Rüschoff, Martina Schmitt, Stefanie Arbogast, Federico Cappuzzo

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Prospective Molecular Marker Analyses of <i>EGFR</i> and <i>KRAS</i> From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Cancer

    Prospective Molecular Marker Analyses of <i>EGFR</i> and <i>KRAS</i> From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non–Small-Cell Lung Ca... by Wolfram Brugger, Nadja Triller, Maria Błasińska-Morawiec, S. Curescu, Raimundas Sakalauskas, Georgy M. Manikhas, Julien Mazières, Renaud Whittom, Carol Ward, Karen Mayne, Kerstin Trunzer, Federico Cappuzzo

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group

    A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group by Tao Jiang, Chunxia Su, Shengxiang Ren, Federico Cappuzzo, Gaetano Rocco, Joshua D. Palmer, Nico van Zandwijk, Fiona Blackhall, Xiuning Le, Nathan A. Pennell, Caicun Zhou

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients

    Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients by Carmelo Tibaldi, Elisa Giovannetti, Marcello Tiseo, Leticia G. León, Armida D’Incecco, Nienke Loosekoot, Marco Bartolotti, Richard J. Honeywell, Federico Cappuzzo, Andrea Ardizzoni, Godefridus J. Peters

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC

    TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC by Benjamin Levy, Enriqueta Felip, Martin Reck, James Chih‐Hsin Yang, Federico Cappuzzo, Yasuto Yoneshima, Caicun Zhou, Siddhartha Rawat, Jingdong Xie, Priyanka Basak, Lu Xu, Jacob Sands

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer

    The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer by Robert M. Gemmill, Patrick Nasarre, Joyce Nair-Menon, Federico Cappuzzo, Lorenza Landi, Armida D’Incecco, Hidetaka Uramoto, Takeshi Yoshida, Eric B. Haura, Kent Armeson, Harry A. Drabkin

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: